Healthcare provider profile · identity verified

Kenneth A Perez, DO

Family Practice · AUSTIN, TX · NPI 1649286907

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	347	89
Losartan Potassium	Losartan Potassium	259	68
Montelukast Sodium	Montelukast Sodium	206	92
Amlodipine Besylate	Amlodipine Besylate	178	55
Metformin Hcl	Metformin Hcl	169	41
Pravastatin Sodium	Pravastatin Sodium	165	45
Levothyroxine Sodium	Levothyroxine Sodium	140	34
Metformin Hcl Er	Metformin Hcl	140	34
Lisinopril	Lisinopril	124	33
Jardiance	Empagliflozin	118	23
Pantoprazole Sodium	Pantoprazole Sodium	118	36
Pioglitazone Hcl	Pioglitazone Hcl	116	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	115	30
Metoprolol Succinate	Metoprolol Succinate	112	38
Meloxicam	Meloxicam	111	50
Omeprazole	Omeprazole	105	25
Rosuvastatin Calcium	Rosuvastatin Calcium	92	31
Albuterol Sulfate Hfa	Albuterol Sulfate	85	48
Gabapentin	Gabapentin	81	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	80	19
Trulicity	Dulaglutide	76	14
Azithromycin	Azithromycin	72	65
Tamsulosin Hcl	Tamsulosin Hcl	68	25
Dexamethasone	Dexamethasone	65	62
Tizanidine Hcl	Tizanidine Hcl	62	42
Famotidine	Famotidine	58	20
Trazodone Hcl	Trazodone Hcl	57	16
Doxycycline Hyclate	Doxycycline Hyclate	56	48
Mounjaro	Tirzepatide	55	12
Paxlovid	Nirmatrelvir/Ritonavir	55	55
Fluticasone Propionate	Fluticasone Propionate	52	15
Prednisone	Prednisone	48	45
Clonazepam	Clonazepam	44	suppressed
Nabumetone	Nabumetone	43	20
Glipizide	Glipizide	42	suppressed
Azelastine Hcl	Azelastine Hcl	41	24
Ipratropium Bromide	Ipratropium Bromide	41	37
Alprazolam	Alprazolam	37	suppressed
Farxiga	Dapagliflozin Propanediol	37	suppressed
Valacyclovir	Valacyclovir Hcl	37	suppressed
Ozempic	Semaglutide	36	suppressed
Potassium Chloride	Potassium Chloride	36	suppressed
Simvastatin	Simvastatin	35	suppressed
Carvedilol	Carvedilol	34	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	34
Fenofibrate	Fenofibrate	34	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	34	suppressed
Clopidogrel	Clopidogrel Bisulfate	33	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Furosemide	Furosemide	32	12
Glipizide Er	Glipizide	31	suppressed
Methylprednisolone	Methylprednisolone	31	31
Mirtazapine	Mirtazapine	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	22
Pregabalin	Pregabalin	30	11
Allopurinol	Allopurinol	29	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	26
Donepezil Hcl	Donepezil Hcl	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	25
Hydroxyzine Hcl	Hydroxyzine Hcl	28	20
Gemfibrozil	Gemfibrozil	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Tramadol Hcl	Tramadol Hcl	25	16
Chlorthalidone	Chlorthalidone	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	23	suppressed
Naproxen	Naproxen	23	suppressed
Meclizine Hcl	Meclizine Hcl	22	12
Triamcinolone Acetonide	Triamcinolone Acetonide	22	11
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Ketoconazole	Ketoconazole	20	14
Mupirocin	Mupirocin	20	19
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Sertraline Hcl	Sertraline Hcl	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	12
Eszopiclone	Eszopiclone	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Cephalexin	Cephalexin	18	17
Duloxetine Hcl	Duloxetine Hcl	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Ondansetron Odt	Ondansetron	18	11
Clobetasol Propionate	Clobetasol Propionate	17	13
Buspirone Hcl	Buspirone Hcl	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Diazepam	Diazepam	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Eliquis	Apixaban	15	suppressed
Amoxicillin	Amoxicillin	14	13
Ezetimibe	Ezetimibe	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Acarbose	Acarbose	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Betamethasone Valerate	Betamethasone Valerate	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Topiramate	Topiramate	13	suppressed
Invokana	Canagliflozin	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	11	suppressed
Nystatin	Nystatin	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error